Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin in Progressive Smoldering Multiple Myeloma
NCT00503763Phase 2Withdrawn
- Sponsor
- Meir Medical Center
- Start
- Sep 2007
- Primary completion
- Mar 2009
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of simvastatin in smoldering multiple myeloma (SMM), sponsored by Meir Medical Center. Planned start Sep 2007; status: withdrawn.
02
Drugs
simvastatin
03
Conditions
smoldering multiple myeloma (SMM)
Beyond the preview
Go deeper on NCT00503763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00503763.